17.11.2012 Views

WAVLD Symposium Handbook_V4.indd - csiro

WAVLD Symposium Handbook_V4.indd - csiro

WAVLD Symposium Handbook_V4.indd - csiro

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

World Association of Veterinary Laboratory Diagnosticians – 13 th International <strong>Symposium</strong>, Melbourne, Australia, 11-14 November 2007<br />

1100 - 1230 Concurrent Session 1.1 - New & Emerging Diseases/Wildlife Mon<br />

EXPERIMENTAL MODELS FOR HENIPAVIRUS INFECTION: BATS, CATS AND PSEUDO-RATS.<br />

12<br />

Bruce A. Mungall, Deborah J. Middleton, Kim Halpin, Peter Daniels, and John Bingham.<br />

Australian Animal Health Laboratory, CSIRO Livestock Industries, 5 Portarlington Rd, Geelong, Australia<br />

Introduction:<br />

November<br />

Hendra virus (HeV) and Nipah virus (NiV), comprising the genus Henipavirus, family Paramyxoviridae, have<br />

been responsible for numerous outbreaks of zoonotic disease in livestock and humans. Bats of the genus<br />

Pteropus have been identified as the reservoir hosts for these viruses. However, how virus spills over from<br />

the reservoir host has remained a mystery. Nipah virus has continued to re-emerge in Asia, specifically<br />

Bangladesh, since 2001, with case fatality rates as high as 92%. As there are no currently available vaccines<br />

or antivirals indicated for Henipavirus infection, possible therapeutic and prophylactic options in the treatment<br />

and prevention of Nipah virus disease has been seen as a priority in this field of research. In addition to<br />

novel emerging pathogens, Henipaviruses are also BSL4 agents that possess several biological features<br />

that make them highly adaptable for use as bioterror agents. Clearly, there is a high level of public health<br />

importance attributed to Henipaviruses, and by inference, a considerable risk associated with new<br />

emergence events by other unknown or as yet, uncharacterised paramyxoviruses.<br />

Material & methods:<br />

Understanding the amplifying host, the routes of transmission, the type of susceptible human hosts, and the<br />

epicentres for zoonotic and human transmissions is crucial in the control of zoonotic infections. There have<br />

been multiple recent paramyxovirus emergence events, many of these involving bats. Some of these newly<br />

emerged viruses are highly pathogenic (henipaviruses), some are moderately pathogenic (Menangle, PoRV,<br />

PPMV) while many are of unknown pathogenicity (Tioman, Mapuera, SalV, TPMV). The development or<br />

characterization of animal models to study these newly identified viral zoonoses is important for<br />

understanding their pathogenic features and in the development of therapeutics or vaccines. In order to<br />

address the different angles of Henipavirus research, we have developed a range of experimental animal<br />

models including bats, pigs, cats, guinea pigs and ferrets, all amenable to BSL4 conditions. This<br />

presentation describes these models.<br />

Results:<br />

While the human symptoms of NiV infection range from fever and headache to severe acute febrile<br />

encephalitis [1], the porcine disease is primarily a febrile respiratory illness with or without neurological signs<br />

[3]. In both humans and pigs, NIV pathogenesis appears to be related to a systemic vasculitis [3, 5] and<br />

experimental infection of cats, hamsters and ferrets has revealed a similar underlying pathology [3, 4, 6]<br />

(Middleton, unpublished data). While guinea pigs have also been experimentally infected with HeV [2]<br />

(Halpin et al., Manuscript in preparation) and NiV (Halpin et al., Manuscript in preparation), the pathology<br />

differed significantly in several respects from the human cases and from naturally and experimentally<br />

infected horses. NiV and HeV do not cause disease in mice even after subcutaneous administration, and<br />

there is no serological evidence for NiV in rodents in Malaysia. However, and not surprisingly, HeV and NiV<br />

will kill mice if administered intracranially but the lack of natural infection precludes the establishment of<br />

useful rodent models.<br />

Discussions & conclusions:<br />

While the cat represents the animal model in which the pathology most closely resembles the lethal disease<br />

course in humans, and will provide an excellent model for some studies, the ferret provides an excellent<br />

more economical model for preliminary therapeutic testing. The high level of similarity between the two<br />

viruses enables therapeutic studies to be carried out for both pathogens in parallel in ferrets followed by cats.<br />

References:<br />

1. Goh et al., Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J<br />

Med, 2000. 342(17): p. 1229-35.<br />

2. Hooper et al., Lesions of experimental equine morbillivirus pneumonia in horses. Veterinary<br />

Pathology, 1997. 34: p. p312-322.<br />

3. Middleton etal., Experimental Nipah virus infection in pigs and cats. J Comp Pathol, 2002. 126(2-3):<br />

p. 124-36.<br />

4. Mungall et al., Feline model of acute nipah virus infection and protection with a soluble glycoproteinbased<br />

subunit vaccine. J Virol, 2006. 80(24): p. 12293-302.<br />

5. Wong et al., Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral<br />

zoonosis. Am J Pathol, 2002. 161(6): p. 2153-67.<br />

6. Wong et al., A golden hamster model for human acute Nipah virus infection. Am J Pathol, 2003.<br />

163(5): p. 2127-37.<br />

Mon 12 November<br />

World Association of Veterinary Laboratory Diagnosticians – 13 th International <strong>Symposium</strong>, Melbourne, Australia, 11-14 November 2007<br />

THE EMERGENCE OF CANINE INFLUENZA IN THE USA: THE RELATIONSHIP TO<br />

EQUINE INFLUENZA AND DEVELOPMENTS SINCE DISCOVERY IN 2004.<br />

P.C. Crawford 1 , T.L. Anderson 1 , W.L. Castleman 1 , M.T. Long 1 , R.O. Donis 2 , T.E. Chambers 3 ,<br />

E.P.J. Gibbs 1* .<br />

1 College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.<br />

2 Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.<br />

3 OIE International Reference Laboratory for Equine Influenza, Gluck Equine Research Center, University of Kentucky, Lexington, KY,<br />

USA.<br />

In 2004, an influenza virus was isolated from an outbreak of severe respiratory diseases in racing<br />

greyhounds at a track in Florida. Several dogs died of pulmonary haemorrhage. An influenza virus was<br />

isolated and the entire genome was sequenced. It was concluded that all eight genes had originated from<br />

equine influenza virus (H3N8), consistent with cross-species transfer from horse to dog. The details of the<br />

discovery of canine influenza and the characterization of the virus have been published (Crawford et al.<br />

2005, Science 310, 482-485). This paper reviews the features of subsequent outbreaks of canine influenza<br />

in Florida and other states within the USA, and reports on the susceptibility of horses to the canine isolate.<br />

Since 2004, canine influenza has been confirmed in multiple outbreaks of respiratory disease at greyhound<br />

tracks throughout the USA and the virus has spread into the pet dog population, particularly those dogs<br />

housed in shelters. The disease has been confirmed by serology and virus isolation in pet dogs in 25 states<br />

in the contiguous USA. Molecular characterizations of recent isolates indicate that the virus is continuing to<br />

evolve. Horses experimentally inoculated with the canine virus were infected as evidenced by<br />

seroconversion and virus replication in pulmonary tissues, but clinical disease was mild.<br />

The paper will discuss the relevance of this discovery to the recent epidemic of equine influenza in Australia.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!